[Skip to Content]
[Skip to Content Landing]
Citations 0
Capitol Health Call
January 12, 2005

Flu Vaccine Probe

JAMA. 2005;293(2):151. doi:10.1001/jama.293.2.151-b

Members of Congress are seeking answers to the question of why the United States was faced with a shortage of vaccines for the 2004-2005 flu season. Two House and one Senate committee held hearings in November questioning federal regulators and flu vaccine manufacturer Chiron Corp of Emeryville, Calif, about the vaccine problem.

Chiron was expected to provide about half of the 100 million doses of flu vaccine that had been ordered for US residents for the flu season. But contamination problems at its production plant in England caused British regulators to suspend the company’s manufacturing license for 3 months, effectively cutting off the US vaccine supply for this flu season.

First Page Preview View Large
First page PDF preview
First page PDF preview